Rescue Hearing Inc scientific advisor Dr. Zheng-Yi Chen of Massachusetts Eye and Ear Infirmary has published a new study entitled “Treatment of autosomal dominant he...
THE NEXT LOGICAL STEP In January 2015, I read a New York Times article by Andrew Pollack entitled “Ear Ailments are New Focus for Drugs from Vertigo to Tinnitus”....
Profiles in Courage I’m not sure who coined the phrase “to the pioneers go the arrows” but I’ve found this to be true across most worthy endeavors from civil righ...
The “Build-to-Buy”Framework Three parties are used: (a) a science company with a novel technology, (b) a venture capital firm and (c) a big pharma com...
First-in-man Somebody’s got to be the first, the pioneer, the risk taker. Two publicly traded companies, Genvec (NASDAQ:GNVC) and its big pharma partner, No...
Profiles in Courage? It may be presumptuous to borrow the title “Profiles in Courage” from the 1957 Pulitzer Prize winning book to describe the scientists w...
My interest in the hearing loss space was sparked after reading a January 2015 New York Times article by Andrew Pollack entitled “Ear Ailments are New Focus for Drug...
AUGUST 2018: Rescue Hearing Inc (RHI) has signed a Sponsored Research Agreement with the University of Kansas Medical Center Research Institute. RHI will be co...
July 18, 2018: Rescue Hearing Inc (RHI) has signed a Sponsored Research Agreement with Massachusetts Eye and Ear. RHI will be conducting research to deve...